ARTICLE | Clinical News
Quadra-Logic Technologies Inc. regulatory update
April 18, 1994 7:00 AM UTC
Quadra-Logic Technologies Inc. (QLTIF) The Vancouver company submitted an NDA and three PMAs to the FDA for approval to market Photofrin, its light-activated drug, as a palliative treatment for parti...